Sobek AI develops a platform that utilizes Generative AI to optimize complex workflows in upstream drug discovery and biologics manufacturing by converting historical data and operational logs into actionable insights. This technology enables subject matter experts to navigate intricate processes, reduce experimental risks, and enhance efficiency in high-stakes environments.
Funding
Funding not disclosed
Founders
Product
Problem
Upstream drug discovery and biologics manufacturing involve complex workflows with numerous potential paths, varying risks, and lengthy experimental cycles. Subject matter experts often struggle to efficiently navigate these intricate processes, leading to increased experimental risks and reduced overall efficiency.
Solution
Sobek AI offers a Generative AI-powered platform designed to optimize complex, high-expertise workflows in upstream drug discovery and biologics manufacturing. The platform converts historical data, operational logs, and standard operating procedures into actionable insights, providing subject matter experts with a "GPS" to navigate the landscape of possibilities. By evaluating, optimizing, and troubleshooting workflows during both planning and execution stages, Sobek AI enables users to identify unknowns, reduce experimental risks, and enhance efficiency in high-stakes environments. The platform facilitates informed decision-making, accelerates healthcare breakthroughs, and ensures broad accessibility, particularly for LMIC and nonprofit organizations.
Target Audience
The primary target audience includes subject matter experts in the life sciences industries, particularly those involved in upstream drug discovery and biologics manufacturing, as well as LMIC and nonprofit organizations.
Features
- Generative AI models that convert prior learnings, event logs, signal captures, and evaluations into actionable insights.
- Workflow optimization tools for evaluating and troubleshooting complex processes during planning and execution.
- Risk assessment capabilities to identify and mitigate potential experimental risks.
- A "GPS for Frontier Workflows" that guides subject matter experts through the terrain of possibilities.
- Support for designing and executing experiments in upstream drug discovery with expensive equipment and lengthy step-cycles.
- Tools for pre-manufacturing of novel and fragile biologics.
- Exception resolution capabilities for manufacturing processes.